Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Bayer nabs 1st-in-class FDA nod for stroke med asundexian
The FDA has signed off on Bayer’s factor XIa inhibitor asundexian, ushering in one of the first major revolutions in stroke prevention in decades.
Fraiser Kansteiner
Nov 9, 2026 9:10pm
Veradermics’ oral hair loss drug passes 1-year ph. 3 test
Nov 9, 2026 2:52pm
Asking More of Science: How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care
Brought to you by
Daiichi Sankyo, Inc.
FDA probes Novartis’ Zolgensma gene therapy over cancer risks
Nov 9, 2026 11:14am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
J&J’s Icotyde pill drives biologic-like efficacy again
Nov 9, 2026 10:02am
